DaVita Inc. logo

DaVita Inc. (TRL)

Market Open
4 Dec, 07:06
XFRA XFRA
101. 05
+0.2
+0.2%
- Market Cap
16.41 P/E Ratio
0% Div Yield
0 Volume
7.83 Eps
100.85
Previous Close
Day Range
101.05 101.05
Year Range
98.7 172.05
Want to track TRL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days

Summary

TRL trading today higher at €101.05, an increase of 0.2% from yesterday's close, completing a monthly decrease of -0.93% or €0.95. Over the past 12 months, TRL stock lost -30.43%.
TRL is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2025, missed the consensus estimates by -3.17%. On average, the company has fell short of earnings expectations by -1.06%, based on the last three reports. The next scheduled earnings report is due on Feb 12, 2026.
DaVita Inc. has completed 1 stock splits, with the recent split occurring on Sep 09, 2013.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NYSE (USD).

TRL Chart

DaVita: More Volatile But Better Upside Than Fresenius

DaVita: More Volatile But Better Upside Than Fresenius

DaVita (DVA) is rated a speculative 'Buy,' reflecting undervaluation despite recent earnings volatility. DVA's moat stems from its dominant US dialysis clinic network, but its reliance on Medicare reimbursement and lack of dividend heighten risk. Trading below 11.5x P/E, DVA offers potential double-digit annual returns if it reverts to historical valuation multiples.

Seekingalpha | 2 days ago
DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

DaVita Inc. ( DVA ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 11:20 AM EST Company Participants Joel Ackerman - CFO & Treasurer Conference Call Participants Justin Lake - Wolfe Research, LLC Presentation Justin Lake Wolfe Research, LLC All right. Good morning.

Seekingalpha | 2 weeks ago
3 Warren Buffett Stocks to Buy Hand Over Fist in November

3 Warren Buffett Stocks to Buy Hand Over Fist in November

DaVita is cheap considering its long-term growth potential. Buy Kraft Heinz for its high yield, stay for the restructuring that could unlock the food company's underlying value.

Fool | 1 month ago

DaVita Inc. (TRL) FAQ

What is the stock price today?

The current price is €101.05.

On which exchange is it traded?

DaVita Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is TRL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 3.19.

When is the next earnings date?

The next earnings report will release on Feb 12, 2026.

Has DaVita Inc. ever had a stock split?

DaVita Inc. had 1 splits and the recent split was on Sep 09, 2013.

DaVita Inc. Profile

- Industry
- Sector
Javier J. Rodriguez CEO
XFRA Exchange
US23918K1088 ISIN
US Country
76,000 Employees
- Last Dividend
9 Sep 2013 Last Split
31 Oct 1995 IPO Date

Overview

DaVita Inc. is a leading healthcare provider specializing in kidney dialysis services for patients grappling with chronic kidney failure across the United States. Initially known as DaVita HealthCare Partners Inc., the company underwent a rebranding to DaVita Inc. in September 2016. Since its establishment in 1994, DaVita has been committed to delivering exceptional care and support to patients with end-stage renal disease (ESRD). With its headquarters located in Denver, Colorado, DaVita operates an extensive network of kidney dialysis centers, complemented by various outpatient and inpatient services designed to cater to the comprehensive needs of individuals undergoing dialysis treatment.

Products and Services

  • Outpatient Hemodialysis Services:

    DaVita provides essential dialysis treatment in its outpatient centers, ensuring patients receive the necessary care without the need for hospital admission. These services cater to the routine management of kidney failure.

  • Hospital Inpatient Hemodialysis Services:

    For patients who are hospitalized and cannot visit an outpatient center, DaVita offers in-hospital hemodialysis. This ensures continuity of care even during acute medical conditions.

  • Home-Based Hemodialysis Services:

    Understanding the need for comfort and convenience, DaVita supports home-based dialysis treatments. This option empowers patients to manage their condition in the familiar surroundings of their homes.

  • Clinical Laboratory Services:

    Operational clinical laboratories provide routine and physician-prescribed laboratory tests specifically designed for ESRD patients, ensuring comprehensive monitoring and management of their condition.

  • Management and Administrative Services:

    DaVita offers extensive management and administrative support to outpatient dialysis centers, encompassing both company-operated and partnered facilities to ensure they operate efficiently and deliver high-quality care.

  • Integrated Care and Disease Management:

    In certain risk-based and integrated care arrangements, DaVita extends beyond dialysis by providing coordinated care and disease management services to address the overall health needs of their patients.

  • Clinical Research Programs:

    Dedicated to advancing knowledge and treatments for kidney disease, DaVita participates in and leads clinical research studies, contributing to the development of innovative care practices.

  • Physician Services:

    A comprehensive network of physicians working with DaVita ensures expert medical care and consultation for patients, aiding in the efficient management of kidney disease.

  • Comprehensive Kidney Care Services:

    Through a holistic approach, DaVita offers extensive kidney care services, including patient education, nutritional counseling, and support groups, to aid in the overall wellbeing of individuals with kidney disease.

  • Acute Inpatient Dialysis Services:

    For patients who require more intensive dialysis treatment while hospitalized, DaVita provides acute inpatient dialysis services, ensuring critical care needs are met.

  • Transplant Software Business:

    DaVita also engages in the development and maintenance of transplant software, facilitating the management and tracking of kidney transplant processes and patient data.

Contact Information

Address: 2000 16th Street
Phone: 720 631 2100